Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load

Lauren K. Walsh, Robert M. Restaino, Martha Neuringer, Camila Manrique, Jaume Padilla

    Research output: Contribution to journalArticle

    14 Citations (Scopus)

    Abstract

    Postprandial hyperglycaemia leads to a transient impairment in endothelial function; however, the mechanisms remain largely unknown. Previous work in cell culture models demonstrate that high glucose results in endoplasmic reticulum (ER) stress and, in animal studies, ER stress has been implicated as a cause of endothelial dysfunction. In the present study, we tested the hypothesis that acute oral administration of tauroursodeoxycholic acid (TUDCA, 1500 mg), a chemical chaperone known to alleviate ER stress, would prevent hyperglycaemia-induced endothelial dysfunction. In 12 young healthy subjects (seven men, five women), brachial artery flow-mediated dilation (FMD) was assessed at baseline, and at 60 and 120 min after an oral glucose challenge. Subjects were tested on two separate visits in a single-blind randomized cross-over design: after oral ingestion of TUDCA or placebo capsules. FMD was reduced from baseline during hyperglycaemia under the placebo condition (-32% at 60 min and -28% at 120 min post oral glucose load; P<0.05 from baseline) but not under the TUDCA condition (-4% at 60 min and +0.3% at 120 min post oral glucose load; P>0.05 from baseline). Postprandial plasma glucose and insulin were not altered by TUDCA ingestion. Plasma oxidative stress markers 3-nitrotyrosine and thiobarbituric acid reactive substance (TBARS) remained unaltered throughout the oral glucose challenge in both conditions. These results suggest that hyperglycaemia-induced endothelial dysfunction can be mitigated by oral administration of TUDCA, thus supporting the hypothesis that ER stress may contribute to endothelial dysfunction during postprandial hyperglycaemia.

    Original languageEnglish (US)
    Pages (from-to)1881-1888
    Number of pages8
    JournalClinical science (London, England : 1979)
    Volume130
    Issue number21
    DOIs
    StatePublished - Nov 1 2016

    Fingerprint

    Endoplasmic Reticulum Stress
    Hyperglycemia
    Glucose
    Oral Administration
    Dilatation
    Eating
    Placebos
    Brachial Artery
    Thiobarbituric Acid Reactive Substances
    Cross-Over Studies
    Capsules
    Healthy Volunteers
    Oxidative Stress
    Cell Culture Techniques
    tauroursodeoxycholic acid
    Insulin

    Keywords

    • endothelial function
    • ER stress
    • postprandial hyperglycaemia
    • tauroursodeoxycholic acid (TUDCA)

    ASJC Scopus subject areas

    • Medicine(all)

    Cite this

    Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. / Walsh, Lauren K.; Restaino, Robert M.; Neuringer, Martha; Manrique, Camila; Padilla, Jaume.

    In: Clinical science (London, England : 1979), Vol. 130, No. 21, 01.11.2016, p. 1881-1888.

    Research output: Contribution to journalArticle

    Walsh, Lauren K. ; Restaino, Robert M. ; Neuringer, Martha ; Manrique, Camila ; Padilla, Jaume. / Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. In: Clinical science (London, England : 1979). 2016 ; Vol. 130, No. 21. pp. 1881-1888.
    @article{4cb687e2322d4088893de12a9f672703,
    title = "Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load",
    abstract = "Postprandial hyperglycaemia leads to a transient impairment in endothelial function; however, the mechanisms remain largely unknown. Previous work in cell culture models demonstrate that high glucose results in endoplasmic reticulum (ER) stress and, in animal studies, ER stress has been implicated as a cause of endothelial dysfunction. In the present study, we tested the hypothesis that acute oral administration of tauroursodeoxycholic acid (TUDCA, 1500 mg), a chemical chaperone known to alleviate ER stress, would prevent hyperglycaemia-induced endothelial dysfunction. In 12 young healthy subjects (seven men, five women), brachial artery flow-mediated dilation (FMD) was assessed at baseline, and at 60 and 120 min after an oral glucose challenge. Subjects were tested on two separate visits in a single-blind randomized cross-over design: after oral ingestion of TUDCA or placebo capsules. FMD was reduced from baseline during hyperglycaemia under the placebo condition (-32{\%} at 60 min and -28{\%} at 120 min post oral glucose load; P<0.05 from baseline) but not under the TUDCA condition (-4{\%} at 60 min and +0.3{\%} at 120 min post oral glucose load; P>0.05 from baseline). Postprandial plasma glucose and insulin were not altered by TUDCA ingestion. Plasma oxidative stress markers 3-nitrotyrosine and thiobarbituric acid reactive substance (TBARS) remained unaltered throughout the oral glucose challenge in both conditions. These results suggest that hyperglycaemia-induced endothelial dysfunction can be mitigated by oral administration of TUDCA, thus supporting the hypothesis that ER stress may contribute to endothelial dysfunction during postprandial hyperglycaemia.",
    keywords = "endothelial function, ER stress, postprandial hyperglycaemia, tauroursodeoxycholic acid (TUDCA)",
    author = "Walsh, {Lauren K.} and Restaino, {Robert M.} and Martha Neuringer and Camila Manrique and Jaume Padilla",
    year = "2016",
    month = "11",
    day = "1",
    doi = "10.1042/CS20160501",
    language = "English (US)",
    volume = "130",
    pages = "1881--1888",
    journal = "Clinical Science",
    issn = "0143-5221",
    publisher = "Portland Press Ltd.",
    number = "21",

    }

    TY - JOUR

    T1 - Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load

    AU - Walsh, Lauren K.

    AU - Restaino, Robert M.

    AU - Neuringer, Martha

    AU - Manrique, Camila

    AU - Padilla, Jaume

    PY - 2016/11/1

    Y1 - 2016/11/1

    N2 - Postprandial hyperglycaemia leads to a transient impairment in endothelial function; however, the mechanisms remain largely unknown. Previous work in cell culture models demonstrate that high glucose results in endoplasmic reticulum (ER) stress and, in animal studies, ER stress has been implicated as a cause of endothelial dysfunction. In the present study, we tested the hypothesis that acute oral administration of tauroursodeoxycholic acid (TUDCA, 1500 mg), a chemical chaperone known to alleviate ER stress, would prevent hyperglycaemia-induced endothelial dysfunction. In 12 young healthy subjects (seven men, five women), brachial artery flow-mediated dilation (FMD) was assessed at baseline, and at 60 and 120 min after an oral glucose challenge. Subjects were tested on two separate visits in a single-blind randomized cross-over design: after oral ingestion of TUDCA or placebo capsules. FMD was reduced from baseline during hyperglycaemia under the placebo condition (-32% at 60 min and -28% at 120 min post oral glucose load; P<0.05 from baseline) but not under the TUDCA condition (-4% at 60 min and +0.3% at 120 min post oral glucose load; P>0.05 from baseline). Postprandial plasma glucose and insulin were not altered by TUDCA ingestion. Plasma oxidative stress markers 3-nitrotyrosine and thiobarbituric acid reactive substance (TBARS) remained unaltered throughout the oral glucose challenge in both conditions. These results suggest that hyperglycaemia-induced endothelial dysfunction can be mitigated by oral administration of TUDCA, thus supporting the hypothesis that ER stress may contribute to endothelial dysfunction during postprandial hyperglycaemia.

    AB - Postprandial hyperglycaemia leads to a transient impairment in endothelial function; however, the mechanisms remain largely unknown. Previous work in cell culture models demonstrate that high glucose results in endoplasmic reticulum (ER) stress and, in animal studies, ER stress has been implicated as a cause of endothelial dysfunction. In the present study, we tested the hypothesis that acute oral administration of tauroursodeoxycholic acid (TUDCA, 1500 mg), a chemical chaperone known to alleviate ER stress, would prevent hyperglycaemia-induced endothelial dysfunction. In 12 young healthy subjects (seven men, five women), brachial artery flow-mediated dilation (FMD) was assessed at baseline, and at 60 and 120 min after an oral glucose challenge. Subjects were tested on two separate visits in a single-blind randomized cross-over design: after oral ingestion of TUDCA or placebo capsules. FMD was reduced from baseline during hyperglycaemia under the placebo condition (-32% at 60 min and -28% at 120 min post oral glucose load; P<0.05 from baseline) but not under the TUDCA condition (-4% at 60 min and +0.3% at 120 min post oral glucose load; P>0.05 from baseline). Postprandial plasma glucose and insulin were not altered by TUDCA ingestion. Plasma oxidative stress markers 3-nitrotyrosine and thiobarbituric acid reactive substance (TBARS) remained unaltered throughout the oral glucose challenge in both conditions. These results suggest that hyperglycaemia-induced endothelial dysfunction can be mitigated by oral administration of TUDCA, thus supporting the hypothesis that ER stress may contribute to endothelial dysfunction during postprandial hyperglycaemia.

    KW - endothelial function

    KW - ER stress

    KW - postprandial hyperglycaemia

    KW - tauroursodeoxycholic acid (TUDCA)

    UR - http://www.scopus.com/inward/record.url?scp=85010982544&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85010982544&partnerID=8YFLogxK

    U2 - 10.1042/CS20160501

    DO - 10.1042/CS20160501

    M3 - Article

    VL - 130

    SP - 1881

    EP - 1888

    JO - Clinical Science

    JF - Clinical Science

    SN - 0143-5221

    IS - 21

    ER -